麻薬の世界市場レポート 2025年

麻薬の市場規模は、今後数年間で安定した成長が見込まれます。2029年には177億9,000万米ドルに成長し、CAGRは4.6%となります。この予測期間における成長は、ジェネリック麻薬の需要拡大、製薬業界の成長、低侵襲手術の需要拡大、緩和ケアにおける麻薬の使用増加などに起因しています。予測期間における主な動向としては、医薬品の技術革新、遠隔医療と遠隔モニタリング、非オピオイド代替薬の開発、創薬・開発における人工知能（AI）の活用などが挙げられます。

麻薬市場の成長は、慢性疾患の罹患率の増加によって牽引されると予想されます。慢性疾患とは、3カ月以上持続し、時間の経過とともに悪化する病気と定義されます。麻薬は、がん、慢性疼痛症候群、末期疾患、重度の関節炎に苦しむ患者を救済し、これらの状態を管理する上で重要な役割を果たしています。例えば、2024年6月、英国の政府機関である国民保健サービス（National Health Service）は、2023年にイングランドで新たに50万人以上（549,000人）が2型糖尿病を発症するリスクがあると確認されたと報告しました。これにより、GPに登録された非糖尿病性高血糖、または糖尿病予備軍の総数は3,615,330人となり、2022年の3,065,825人から20％近く増加しました。その結果、慢性疾患の有病率の増加が麻薬市場の成長を牽引しています。

麻薬市場の成長は、処方薬としてのオピオイド使用の増加によって大きな影響を受けると予想されます。オピオイドは、合法処方薬と違法薬物の両方を含む薬剤クラス別であり、多幸感、リラックス感、鎮静感を誘発することで知られています。オピオイドはその強力な鎮痛・鎮静作用が評価され、特に他の疼痛管理方法では不十分な場合に使用されるためです。例えば、2024年5月、オーストラリアの政府機関であるオーストラリア保健福祉研究所（Australian Institute of Health and Welfare）は、2023年のある日、オーストラリア（西オーストラリア州を除く）でオピオイド依存症の薬物療法を受けている人が53,272人いたと報告しました。このように、処方薬としてのオピオイドの使用が増加していることが、麻薬市場の成長を促進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界麻薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の麻薬市場：成長率分析
• 世界の麻薬市場の実績：規模と成長, 2019-2024
• 世界の麻薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界麻薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の麻薬市場薬物による、実績と予測, 2019-2024, 2024-2029F, 2034F
• アヘン
• ヘロイン
• コデイン
• オキシコドン
• その他の薬物
• 世界の麻薬市場：ソース別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 天然
• 半合成
• 合成
• 世界の麻薬市場適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 疼痛管理
• 咳
• 下痢
• 赤痢
• 喘息
• その他の適応症
• 世界の麻薬市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• オンライン薬局
• 小売薬局
• 世界の麻薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• ホームケア
• 専門クリニック
• その他のエンドユーザー
• 世界の麻薬市場、アヘンの種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生アヘン
• アヘン抽出物
• アヘン誘導体
• 世界の麻薬市場、ヘロインの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ジアセチルモルヒネ
• ヘロイン塩酸塩
• ヘロイン酢酸塩
• 世界の麻薬市場、コデインのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• コデインリン酸
• コデイン硫酸塩
• 世界の麻薬市場、オキシコドンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オキシコドン塩酸塩
• オキシコドンアセトアミノフェン
• 徐放性オキシコドン
• 世界の麻薬市場、その他の医薬品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• フェンタニル
• モルヒネ
• ヒドロモルフォン
• メサドン
• ブプレノルフィン

第7章 地域別・国別分析

• 世界の麻薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の麻薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 麻薬市場：競合情勢
• 麻薬市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson and Johnson Limited Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sanofi S.A.
• Takeda Pharmaceutical Company Limited
• Boehringer Ingelheim International GmbH
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Daiichi Sankyo Company Limited
• Sun Pharmaceutical Industries Ltd.
• Purdue Pharma LP
• Hikma Pharmaceuticals Plc
• Endo Pharmaceuticals Inc.
• Amneal Pharmaceuticals LLC
• Lupin Ltd.
• Mallinckrodt Pharmaceuticals
• Alvogen Inc.
• Indivior Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 麻薬市場2029：新たな機会を提供する国
• 麻薬市場2029：新たな機会を提供するセグメント
• 麻薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A narcotic drug is a class of substances that affect the central nervous system, inducing effects like drowsiness, pain relief, euphoria, and sometimes hallucinations. These drugs are commonly derived from the opium poppy plant but can also be synthesized.

The key types of narcotic drugs include opium, heroin, codeine, oxycodone, and others. Opium is a bitter, brownish, addictive substance derived from the dried latex of immature seed capsules of the opium poppy. These narcotics come from various sources, which can be natural, semi-synthetic, or synthetic, and are used for a range of purposes, including pain management, cough suppression, diarrhea treatment, asthma relief, and more. They are distributed through a variety of channels, including hospital pharmacies, online pharmacies, and retail pharmacies, and are utilized by diverse end-users, such as hospitals, homecare services, specialty clinics, and others.

The narcotic drugs market research report is one of a series of new reports from The Business Research Company that provides narcotic drugs market statistics, including narcotic drugs industry global market size, regional shares, competitors with a narcotic drugs market share, detailed narcotic drugs market segments, market trends and opportunities and any further data you may need to thrive in the narcotic drugs industry. This narcotic drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The narcotic drugs market size has grown steadily in recent years. It will grow from $14.26 billion in 2024 to $14.85 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to increasing medical need, growing public health concerns, increasing access to healthcare, rising prevalence of chronic pain, government initiatives to improve pain management.

The narcotic drugs market size is expected to see steady growth in the next few years. It will grow to $17.79 billion in 2029 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to growing demand for generic narcotic drugs, growing pharmaceutical industry, growing demand for minimally invasive surgeries, increased use of narcotic drugs in palliative care. Major trends in the forecast period include pharmaceutical innovation, telemedicine and remote monitoring, development of non-opioid alternatives, use of artificial intelligence (AI) in drug discovery and development.

The growth of the narcotic drug market is anticipated to be driven by the increasing incidence of chronic diseases. Chronic diseases are defined as illnesses lasting three months or more that can worsen over time. Narcotic drugs play a crucial role in managing these conditions, offering relief for patients suffering from cancer, chronic pain syndrome, terminal illnesses, and severe arthritis. For example, in June 2024, the National Health Service, a UK-based government agency, reported that in 2023, over half a million (549,000) additional individuals in England were identified as being at risk of developing type 2 diabetes. This brought the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330, marking a significant increase from 3,065,825 in 2022, which is nearly a 20% rise. Consequently, the increasing prevalence of chronic diseases is driving the growth of the narcotic drug market.

The growth of the narcotic drugs market is expected to be significantly influenced by the rising use of opioids as prescription medications. Opioids are a class of drugs that encompass both legal prescriptions and illegal substances, known for inducing feelings of euphoria, relaxation, and sedation. Their increasing use in prescription medicine is a key driver of narcotic drug consumption, as opioids are valued for their powerful pain-relieving and sedative effects, particularly when other pain management methods prove inadequate. For example, in May 2024, the Australian Institute of Health and Welfare, a government agency in Australia, reported that on a specific day in 2023, there were 53,272 individuals undergoing pharmacotherapy for opioid dependence in Australia (excluding Western Australia), translating to a rate of 22 clients per 10,000 people. Thus, the growing use of opioids as prescription medications is propelling the growth of the narcotic drugs market.

Prominent companies within the narcotic drug market are placing a growing emphasis on product development and innovation to offer dependable products to their customers and bolster their positions in the market. As an example, in May 2023, Indivior PLC, a pharmaceutical company headquartered in the United States, introduced OPVEE (nalmefene) nasal spray. This product serves as an opioid overdose rescue medication designed for use with natural and synthetic opioids, including substances like fentanyl. It is recommended for immediate use in the treatment of known or suspected opioid overdoses in adults and pediatric patients aged 12 and older, particularly in cases involving respiratory and central nervous system depression. This development underscores the company's commitment to addressing critical medical needs and enhancing the safety of individuals at risk of opioid overdose.

In March 2023, Indivior PLC, a pharmaceutical company based in the United States, completed its acquisition of Opiant Pharmaceuticals Inc. for a total of $145 million. This strategic acquisition is intended to bolster Indivior PLC's portfolio in the field of addiction treatment and science. It is noteworthy that this acquisition includes OPNT003, an investigational opioid overdose treatment, which is seen as a crucial addition to address the ongoing opioid overdose crisis in the United States, particularly involving potent synthetic opioids like fentanyl. Opiant Pharmaceuticals Inc., a pharmaceutical company headquartered in the United States, specializes in the manufacturing of narcotic drugs. This acquisition reflects Indivior PLC's commitment to expanding its offerings in the fight against opioid overdoses and substance use disorders.

Major companies operating in the narcotic drugs market are Pfizer Inc., Johnson and Johnson Limited, AbbVie Inc., Novartis AG, AstraZeneca PLC, Sanofi S.A., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Purdue Pharma LP, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Lupin Ltd., Mallinckrodt Pharmaceuticals, Alvogen Inc., Indivior Inc., Impax Laboratories Inc., Collegium Pharmaceutical Inc., Lannett Co Inc., Par Pharmaceutical Inc., West-Ward Pharmaceuticals Corp.

Asia-Pacific was the largest region in the narcotic drugs market in 2024. The regions covered in the narcotic drug report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the narcotic drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, and Spain.

The narcotic drug market consists of sales of ketobemidone, pethidine, tolidine, and trimeperidine. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Narcotic Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on narcotic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for narcotic drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The narcotic drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug: Opium; Heroin; Codeine; Oxycodone; Other Drugs
• 2) By Source: Natural; Semi-Synthetic; Synthetic
• 3) By Indication: Pain Management; Cough; Diarrhea; Dysentery; Asthma; Other Indications
• 4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
• 5) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Opium: Raw Opium; Opium Extracts; Opium Derivatives
• 2) By Heroin: Diacetylmorphine; Heroin Hydrochloride; Heroin Acetate
• 3) By Codeine: Codeine Phosphate; Codeine Sulfate
• 4) By Oxycodone: Oxycodone Hydrochloride; Oxycodone Acetaminophen; Controlled-Release Oxycodone
• 5) By Other Drugs: Fentanyl; Morphine; Hydromorphone; Methadone; Buprenorphine
• Companies Mentioned: Pfizer Inc.; Johnson and Johnson Limited; AbbVie Inc.; Novartis AG; AstraZeneca PLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Narcotic Drugs Market Characteristics

3. Narcotic Drugs Market Trends And Strategies

4. Narcotic Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Narcotic Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Narcotic Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Narcotic Drugs Market Growth Rate Analysis
• 5.4. Global Narcotic Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Narcotic Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Narcotic Drugs Total Addressable Market (TAM)

6. Narcotic Drugs Market Segmentation

• 6.1. Global Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Opium
• Heroin
• Codeine
• Oxycodone
• Other Drugs
• 6.2. Global Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural
• Semi-Synthetic
• Synthetic
• 6.3. Global Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Management
• Cough
• Diarrhea
• Dysentery
• Asthma
• Other Indications
• 6.4. Global Narcotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• 6.5. Global Narcotic Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End Users
• 6.6. Global Narcotic Drugs Market, Sub-Segmentation Of Opium, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Raw Opium
• Opium Extracts
• Opium Derivatives
• 6.7. Global Narcotic Drugs Market, Sub-Segmentation Of Heroin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diacetylmorphine
• Heroin Hydrochloride
• Heroin Acetate
• 6.8. Global Narcotic Drugs Market, Sub-Segmentation Of Codeine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Codeine Phosphate
• Codeine Sulfate
• 6.9. Global Narcotic Drugs Market, Sub-Segmentation Of Oxycodone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oxycodone Hydrochloride
• Oxycodone Acetaminophen
• Controlled-Release Oxycodone
• 6.10. Global Narcotic Drugs Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fentanyl
• Morphine
• Hydromorphone
• Methadone
• Buprenorphine

7. Narcotic Drugs Market Regional And Country Analysis

• 7.1. Global Narcotic Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Narcotic Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Narcotic Drugs Market

• 8.1. Asia-Pacific Narcotic Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Narcotic Drugs Market

• 9.1. China Narcotic Drugs Market Overview
• 9.2. China Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Narcotic Drugs Market

• 10.1. India Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Narcotic Drugs Market

• 11.1. Japan Narcotic Drugs Market Overview
• 11.2. Japan Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Narcotic Drugs Market

• 12.1. Australia Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Narcotic Drugs Market

• 13.1. Indonesia Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Narcotic Drugs Market

• 14.1. South Korea Narcotic Drugs Market Overview
• 14.2. South Korea Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Narcotic Drugs Market

• 15.1. Western Europe Narcotic Drugs Market Overview
• 15.2. Western Europe Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Narcotic Drugs Market

• 16.1. UK Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Narcotic Drugs Market

• 17.1. Germany Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Narcotic Drugs Market

• 18.1. France Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Narcotic Drugs Market

• 19.1. Italy Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Narcotic Drugs Market

• 20.1. Spain Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Narcotic Drugs Market

• 21.1. Eastern Europe Narcotic Drugs Market Overview
• 21.2. Eastern Europe Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Narcotic Drugs Market

• 22.1. Russia Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Narcotic Drugs Market

• 23.1. North America Narcotic Drugs Market Overview
• 23.2. North America Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Narcotic Drugs Market

• 24.1. USA Narcotic Drugs Market Overview
• 24.2. USA Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Narcotic Drugs Market

• 25.1. Canada Narcotic Drugs Market Overview
• 25.2. Canada Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Narcotic Drugs Market

• 26.1. South America Narcotic Drugs Market Overview
• 26.2. South America Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Narcotic Drugs Market

• 27.1. Brazil Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Narcotic Drugs Market

• 28.1. Middle East Narcotic Drugs Market Overview
• 28.2. Middle East Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Narcotic Drugs Market

• 29.1. Africa Narcotic Drugs Market Overview
• 29.2. Africa Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Narcotic Drugs Market Competitive Landscape And Company Profiles

• 30.1. Narcotic Drugs Market Competitive Landscape
• 30.2. Narcotic Drugs Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson and Johnson Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

31. Narcotic Drugs Market Other Major And Innovative Companies

• 31.1. Sanofi S.A.
• 31.2. Takeda Pharmaceutical Company Limited
• 31.3. Boehringer Ingelheim International GmbH
• 31.4. Viatris Inc.
• 31.5. Teva Pharmaceutical Industries Ltd.
• 31.6. Daiichi Sankyo Company Limited
• 31.7. Sun Pharmaceutical Industries Ltd.
• 31.8. Purdue Pharma LP
• 31.9. Hikma Pharmaceuticals Plc
• 31.10. Endo Pharmaceuticals Inc.
• 31.11. Amneal Pharmaceuticals LLC
• 31.12. Lupin Ltd.
• 31.13. Mallinckrodt Pharmaceuticals
• 31.14. Alvogen Inc.
• 31.15. Indivior Inc.

32. Global Narcotic Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Narcotic Drugs Market

34. Recent Developments In The Narcotic Drugs Market

35. Narcotic Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Narcotic Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Narcotic Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Narcotic Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer